Literature DB >> 23100177

Nodular lesions and mesangiolysis in diabetic nephropathy.

Takashi Wada1, Miho Shimizu, Hitoshi Yokoyama, Yasunori Iwata, Yoshio Sakai, Shuichi Kaneko, Kengo Furuichi.   

Abstract

Diabetic nephropathy is a leading cause of end-stage renal failure all over the world. Advanced human diabetic nephropathy is characterized by the presence of specific lesions including nodular lesions, doughnut lesions, and exudative lesions. Thus far, animal models precisely mimicking advanced human diabetic nephropathy, especially nodular lesions, remain to be fully established. Animal models with spontaneous diabetic kidney diseases or with inducible kidney lesions may be useful for investigating the pathogenesis of diabetic nephropathy. Based on pathological features, we previously reported that diabetic glomerular nodular-like lesions were formed during the reconstruction process of mesangiolysis. Recently, we established nodular-like lesions resembling those seen in advanced human diabetic nephropathy through vascular endothelial injury and mesangiolysis by administration of monocrotaline. Here, in this review, we discuss diabetic nodular lesions and its animal models resembling human diabetic kidney lesions, with our hypothesis that endothelial cell injury and mesangiolysis might be required for nodular lesions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100177     DOI: 10.1007/s10157-012-0711-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  34 in total

1.  Case records of the Massachusetts General Hospital. Case 20-2012. A 77-year-old man with leg edema, hematuria, and acute renal failure.

Authors:  Hasan Bazari; Alexander R Guimaraes; Yael B Kushner
Journal:  N Engl J Med       Date:  2012-06-28       Impact factor: 91.245

2.  Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats.

Authors:  Kengo Furuichi; Yukimasa Hisada; Miho Shimizu; Toshiya Okumura; Kiyoki Kitagawa; Keiichi Yoshimoto; Yasunori Iwata; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Nephrol Dial Transplant       Date:  2011-03-17       Impact factor: 5.992

3.  Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases.

Authors:  S K Ainsworth; H Z Hirsch; N C Brackett; R M Brissie; A V Williams; G R Hennigar
Journal:  Hum Pathol       Date:  1982-05       Impact factor: 3.466

4.  Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.

Authors:  M M Schwartz; E J Lewis; T Leonard-Martin; J B Lewis; D Batlle
Journal:  Nephrol Dial Transplant       Date:  1998-10       Impact factor: 5.992

5.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Authors:  Yukiko Kanetsuna; Keiko Takahashi; Michio Nagata; Maureen A Gannon; Matthew D Breyer; Raymond C Harris; Takamune Takahashi
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

6.  Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients.

Authors:  Tatsumi Moriya; Rika Moriya; Yoshitada Yajima; Michael W Steffes; Michael Mauer
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

7.  Diabetic eNOS knockout mice develop distinct macro- and microvascular complications.

Authors:  Sumathy Mohan; Robert L Reddick; Nicolas Musi; Diane A Horn; Bo Yan; Thomas J Prihoda; Mohan Natarajan; Sherry L Abboud-Werner
Journal:  Lab Invest       Date:  2008-04-07       Impact factor: 5.662

8.  Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients.

Authors:  R Osterby; M A Gall; A Schmitz; F S Nielsen; G Nyberg; H H Parving
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

Review 9.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

10.  Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.

Authors:  Satoshi Miyamoto; Kenichi Shikata; Kyoko Miyasaka; Shinichi Okada; Motofumi Sasaki; Ryo Kodera; Daisho Hirota; Nobuo Kajitani; Tetsuharu Takatsuka; Hitomi Usui Kataoka; Shingo Nishishita; Chikage Sato; Akihiro Funakoshi; Hisakazu Nishimori; Haruhito Adam Uchida; Daisuke Ogawa; Hirofumi Makino
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

View more
  10 in total

1.  Mesangial cell αvβ8-integrin regulates glomerular capillary integrity and repair.

Authors:  Sujata Lakhe-Reddy; Vincent Li; Thomas D Arnold; Shenaz Khan; Jeffrey R Schelling
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-16

2.  The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.

Authors:  Koichi Kanozawa; Yuichi Noguchi; Souichi Sugahara; Satoko Nakamura; Hirohisa Yamamoto; Keiko Kaneko; Rika Kono; Saeko Sato; Tomonari Ogawa; Hajime Hasegawa; Shigehiro Katayama
Journal:  Clin Exp Nephrol       Date:  2017-12-23       Impact factor: 2.801

3.  Nodular glomerulosclerosis in a kidney transplant recipient with impaired glucose tolerance: diabetic or idiopathic? A case report and literature review.

Authors:  Zhong Hong Liew; Puay Hoon Tan; Marjorie Foo; Terence Kee; Quan Yao Ho
Journal:  CEN Case Rep       Date:  2021-01-03

4.  How useful is kidney biopsy for the management of glomerulopathies in the elderly?

Authors:  Otilia Popa; Cristina Capusa; Gabriel Stefan; Eugen Mandache; Simona Stancu; Nicoleta Petre; Gabriel Mircescu
Journal:  J Nephrol       Date:  2022-09-09       Impact factor: 4.393

5.  A case of proliferative glomerulonephritis with monoclonal IgG3κ deposits accompanied by glomerular capillary microaneurysms.

Authors:  Akiko Mii; Mika Terasaki; Shinobu Kunugi; Miyako Seki; Tetsuya Kashiwagi; Yukinao Sakai; Akira Shimizu
Journal:  CEN Case Rep       Date:  2022-01-13

6.  DNA double-strand breaks induced intractable glomerular fibrosis in renal allografts.

Authors:  Yuki Matsui; Yumi Sunatani; Norifumi Hayashi; Kazuaki Okino; Yuki Okushi; Kiyotaka Mukai; Hiroki Adachi; Hideki Yamaya; Kuniyoshi Iwabuchi; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2015-10-06       Impact factor: 2.801

Review 7.  Trajectories of kidney function in diabetes: a clinicopathological update.

Authors:  Megumi Oshima; Miho Shimizu; Masayuki Yamanouchi; Tadashi Toyama; Akinori Hara; Kengo Furuichi; Takashi Wada
Journal:  Nat Rev Nephrol       Date:  2021-08-06       Impact factor: 28.314

8.  Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Masayuki Yamanouchi; Junichi Hoshino; Norihiko Sakai; Yasunori Iwata; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Yukio Yuzawa; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshihiko Ueda; Shinichi Nishi; Tomoya Nishino; Kenichi Samejima; Kentaro Kohagura; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Yoshifumi Ubara; Hitoshi Yokoyama; Takashi Wada
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06

9.  DNA damage in human glomerular endothelial cells induces nodular glomerulosclerosis via an ATR and ANXA2 pathway.

Authors:  Ai Fujii; Yumi Sunatani; Kengo Furuichi; Keiji Fujimoto; Hiroki Adachi; Kuniyoshi Iwabuchi; Hitoshi Yokoyama
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

10.  Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.

Authors:  Miho Shimizu; Kengo Furuichi; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Kiyoki Kitagawa; Yasunori Iwata; Norihiko Sakai; Toshinari Takamura; Mitsuhiro Yoshimura; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.